Atellica IM anti-HBc Total (HBcT)
FDA premarket approval P040004/S014 · decided 2018-09-11
Approval details
- PMA number
- P040004
- Supplement
- S014
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Atellica IM anti-HBc Total (HBcT)
- Generic name
- Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
- Applicant
- Siemens Healthcare Diagnostics
- Date received
- 2018-07-19
- Decision date
- 2018-09-11
- Days to decision
- 54 days
- Decision code
- APPR
- Product code
- LOM
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- East Walpole, MA
- Statement
- Approval for the placement of these assays on the Atellica Solution.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.